AbbVie Reports Second-Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
AbbVie (ABBV) Tops Q2 EPS by 3c, Updates Guidance
July 30, 2021 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q2 EPS of $3.11, $0.03 better than the analyst estimate of $3.08. Revenue for the quarter came in at $13.96 billion versus the consensus estimate of $13.61 billion.
GUIDANCE:
AbbVie sees FY2021 EPS of $12.52-$12.62, versus the consensus of... More
